Protein-Oxidized Phospholipid Interactions Determine Epithelial Cell Fate and Asthma Control
Protein-Oxidized Phospholipid Interactions Determine Epithelial Cell Fate and Asthma Control
批准号:
10593942
负责人:
Valerian E Kagan
金额:
$53.51万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-04-01 至 2025-03-31
关键词:
AcidsAllergensAnimal ModelApoptosisArachidonate 15-LipoxygenaseAsthmaAutomobile DrivingAutophagocytosisBindingBronchoalveolar LavageBronchoalveolar Lavage FluidCell AgingCell DeathCell Differentiation processCell Membrane PermeabilityCell SurvivalCell modelCell physiologyCellsCessation of lifeCultured CellsDataDevelopmentEndogenous FactorsEnzyme InductionEnzymesEpithelial CellsEpitheliumEquilibriumExogenous FactorsGlutathioneGlutathione DisulfideHomeostasisHumanIn VitroInflammationInflammatoryInterleukin-13Interleukin-4IntubationLIGHT proteinLightLipoxygenase 1MacrophageMeasuresMicrotubulesMitochondriaMitochondrial DNAModelingMolecularOxidation-ReductionOxidative StressParticipantPathway interactionsPatientsPhenotypePhosphatidylethanolaminePhosphatidylethanolamine Binding ProteinPhospholipid InteractionPhospholipidsPolyunsaturated Fatty AcidsProcessProliferatingProteinsRecyclingRiskRoleScaffolding ProteinSeveritiesStressTissuesairway epitheliumasthma exacerbationasthmaticasthmatic airwayasthmatic patientcytokineexperiencefallsglutathione peroxidasein vivomitochondrial membranemonocytemouse modelnovelnovel therapeuticspreventrelease factorselenoenzymetargeted agent
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Molecular mechanisms for exacerbation-prone asthma are poorly understood. While a critical role for Type-2
(T2) cytokines is emerging, only 20-25% of T2-Hi patients persistently exacerbate, suggesting additional factors
modulate the risk. Our group recently showed (Cell, 2017) that binding of the T2-enzyme, 15 lipoxygenase 1
(15LO1) to a scaffolding protein, phosphatidyl- ethanolamine (PE) binding protein (PEBP)1, triggers a form of
programmed cell death termed ferroptosis, when it switches the preferred 15LO1 substrate from free
polyunsaturated fatty acids (PUFA), to PUFAs conjugated to PE, specifically 15 hydroperoxyeicosaetetranoic
acid-PE (15 HpETE-PE), which drive ferroptotic cell death. Glutathione peroxidase (GPX)4, an enzyme highly
sensitive to oxidative stress, rapidly converts 15 HpETE-PE to its stable hydroxy-metabolite, 15
hydroxyeicosaetetranoic acid (15 HETE)-PE preventing cell death. PEBP1 also binds the autophagy protein,
microtubule light chain-3 (LC3), limiting autophagy. Expanding on this, we observed IL-13 stimulated LC3
lipidation and lowered mitochondrial numbers in human airway epithelial cells (AECs), all through
15LO1/15HpETE-PE-processes, suggesting concomitant engagement of mitophagy. These effects associate
with high 15LO1-dependent intracellular oxidative stress and are also seen in airway AECs from exacerbation-
prone asthma. Thus, in the presence of a “T2/IL-4/-13 1st hit”, a pro-ferroptotic 15LO1-PEBP pathway is activated,
but potentially limited to a localized disruptive mitochondrial process in association with initiation of
autophagy/mitophagy (without cell death). This GSH-dependent process generates oxidatively vulnerable cells
with increased secretory marker expression and lower proliferation consistent with cell senescence. With an
“oxidative 2nd hit”, GSH falls, lowering GPX4 activity and initiating generalized ferroptosis, disrupting epithelial
barriers, increasing pro-inflammatory factor release and promoting exacerbations. Thus, we hypothesize that
15LO1 and PEBP1, with both GPX4 and LC3, fundamentally regulate the balance between ferroptosis and
mitophagy, influencing cell function, asthma control and exacerbations. Using in vitro and ex vivo human cells
and in vivo animal models we will: 1) Identify the mechanisms by which a T2–associated 1st hit” induces “stressed
homeostasis” in asthmatic airway cells, and its implications for asthma severity and control and 2) define
mechanisms by which an “oxidative 2nd hit” disrupts the “stressed homeostasis” to induce widespread ferroptosis
and promote asthma exacerbations. Thus, we will examine fundamental death and survival pathways in relation
to asthma and determine whether 15LO1-PEBP activity and ferroptosis are viable new targets for asthma and
its exacerbations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapeutic targeting MDSC-mediated immune suppression in cancer
-
批准号:10540357
-
项目类别:
-
资助金额:$68.26万
-
财政年份:2021
-
负责人:Valerian E Kagan
-
依托单位:
Therapeutic targeting MDSC-mediated immune suppression in cancer
-
批准号:10340589
-
项目类别:
-
资助金额:$71.44万
-
财政年份:2021
-
负责人:Valerian E Kagan
-
依托单位:
Selective Inhibitors of Pro-Ferroptotic Lipoxygenases - Next Generation Radiomitigators
-
批准号:10176413
-
项目类别:
-
资助金额:$53.45万
-
财政年份:2020
-
负责人:Valerian E Kagan
-
依托单位:
Selective Inhibitors of Pro-Ferroptotic Lipoxygenases - Next Generation Radiomitigators
-
批准号:10408142
-
项目类别:
-
资助金额:$40.88万
-
财政年份:2020
-
负责人:Valerian E Kagan
-
依托单位:
Protein-Oxidized Phospholipid Interactions Determine Epithelial Cell Fate and Asthma Control
-
批准号:10375454
-
项目类别:
-
资助金额:$54.0万
-
财政年份:2020
-
负责人:Valerian E Kagan
-
依托单位:
The molecular basis of cardiolipin-protein interactions implicated in intrinsic apoptosis
-
批准号:9342976
-
项目类别:
-
资助金额:$36.58万
-
财政年份:2016
-
负责人:Valerian E Kagan
-
依托单位:
Ferroptosis as a Death Mechanism in Lung Injury - Project 2
-
批准号:10399560
-
项目类别:
-
资助金额:$36.74万
-
财政年份:2014
-
负责人:Valerian E Kagan
-
依托单位:
NANOTOX 2014, 7th International Nanotoxicology Congress
-
批准号:8718354
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2014
-
负责人:Valerian E Kagan
-
依托单位:
Intra- and extra-cellular signaling by Cardiolipin in Lung injury
-
批准号:8643330
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2014
-
负责人:Valerian E Kagan
-
依托单位:
Oxidative Lipidomics Core
-
批准号:8643333
-
项目类别:
-
资助金额:$20.13万
-
财政年份:2014
-
负责人:Valerian E Kagan
-
依托单位:
Ferroptosis as a Death Mechanism in Lung Injury - Project 2
-
批准号:10631057
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2014
-
负责人:Valerian E Kagan
-
依托单位:
Ferroptosis as a Death Mechanism in Lung Injury - Project 2
-
批准号:10204081
-
项目类别:
-
资助金额:$36.74万
-
财政年份:2014
-
负责人:Valerian E Kagan
-
依托单位:
Lipids and Myeloid Cell Function in Cancer
-
批准号:10435498
-
项目类别:
-
资助金额:$39.42万
-
财政年份:2012
-
负责人:Valerian E Kagan
-
依托单位:
Lipids and Myeloid Cell Function in Cancer
-
批准号:10021537
-
项目类别:
-
资助金额:$40.22万
-
财政年份:2012
-
负责人:Valerian E Kagan
-
依托单位:
Imaging Mass Spectrometry for Oxidized Lipidomics in Acute Lung Injury
-
批准号:8234264
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2012
-
负责人:Valerian E Kagan
-
依托单位:
Lipids and Myeloid Cell Function in Cancer
-
批准号:10202494
-
项目类别:
-
资助金额:$40.22万
-
财政年份:2012
-
负责人:Valerian E Kagan
-
依托单位:
Imaging Mass Spectrometry for Oxidized Lipidomics in Acute Lung Injury
-
批准号:8423711
-
项目类别:
-
资助金额:$18.56万
-
财政年份:2012
-
负责人:Valerian E Kagan
-
依托单位:
Oxygenated Species of Cardiolipins as Biomarkers of Mitochondrial Dysfunction
-
批准号:8691815
-
项目类别:
-
资助金额:$33.75万
-
财政年份:2011
-
负责人:Valerian E Kagan
-
依托单位:
Oxygenated Species of Cardiolipins as Biomarkers of Mitochondrial Dysfunction
-
批准号:8334604
-
项目类别:
-
资助金额:$34.09万
-
财政年份:2011
-
负责人:Valerian E Kagan
-
依托单位:
Oxygenated Species of Cardiolipins as Biomarkers of Mitochondrial Dysfunction
-
批准号:8485605
-
项目类别:
-
资助金额:$33.41万
-
财政年份:2011
-
负责人:Valerian E Kagan
-
依托单位:
海外基金